U.S. markets closed

Stereotaxis, Inc. (STXS)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
5.82+0.14 (+2.46%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close5.68
Bid5.75 x 1100
Ask5.89 x 1100
Day's Range5.55 - 5.86
52 Week Range3.03 - 10.30
Avg. Volume434,245
Market Cap433.634M
Beta (5Y Monthly)1.40
PE Ratio (TTM)N/A
EPS (TTM)-0.10
Earnings DateNov 08, 2021 - Nov 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Stereotaxis, Inc.
    EW: Lowering target price to $127.00EDWARDS LIFESCIENCES CORP has an Investment Rating of HOLD; a target price of $127.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • GlobeNewswire

    Stereotaxis to Present at Upcoming Investor Conferences

    ST. LOUIS, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and CEO, will present at two investor conferences in September 2021. Lake Street 5th Annual Best Ideas Growth ConferenceMr. Fischel will be available for one-on-one meetings on Wednesday, September 15, 2021. Cantor Virtual Global Healthcare ConferenceMr. Fischel will present an overview

  • GlobeNewswire

    Stereotaxis and MicroPort EP Collaborate to Advance Innovation and Adoption of Robotic Electrophysiology in China

    ST. LOUIS and SHANGHAI, China, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai Microport EP Medtech Co., Ltd. (“MicroPort EP”) today announced a broad collaboration to advance technology innovation and commercial adoption of robotics in electrophysiology in China. The agreement brings together MicroPort EP’s commercial and product leadership in China’s electrophysiology market with Stereotaxis’ advanced Robotic Magnetic Navigation technology. As part of the collaboration,

  • Motley Fool

    Stereotaxis (STXS) Q2 2021 Earnings Call Transcript

    STXS earnings call for the period ending June 30, 2021.